Well, this is very interesting.
Of the 3 mice treated, it showed significant improvement when compared to: untreated, only light and only INV043.
"There was no significant difference in tumour size between any group until day 19 of tumour
growth (four days following treatment #2), when tumour size reduced substantially in treated
animals compared to all control groups."
The market should like this result.
Ann: Further Information on Proof of Concept Pilot Study, page-2
Add IVX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $25.69M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.4¢ | $3.46K | 692.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 24777252 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 1576882 | 3 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
-0.001 ( 10.0 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 1662 | ||
| Last updated 15.10pm 30/05/2024 ? | |||||
| IVX (ASX) Chart |